Detalhe da pesquisa
1.
Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study.
BMC Cancer
; 18(1): 51, 2018 01 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29310623
2.
Trastuzumab in Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: Results of a Prospective, Noninterventional Study on Routine Treatment Between 2006 and 2012 in Germany.
Oncologist
; 22(2): 131-138, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28174294
3.
A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer.
BMC Cancer
; 10: 2, 2010 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20047698
4.
The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Clin Breast Cancer
; 17(2): 100-106, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27884722
5.
Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial.
Breast Cancer
; 24(2): 319-325, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27262301
6.
Concordance rates of biomarkers uPA and PAI-1 results in primary breast cancer vs. consecutive tumor board decision and therapy performed in clinical hospital routine: Results of a prospective multi-center study at certified breast centers.
Breast
; 29: 208-12, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27344290
7.
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
Breast
; 27: 69-77, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27054751
8.
Treosulfan in the Treatment of Advanced Ovarian Cancer - Results of a German Multicenter Non-interventional Study.
Anticancer Res
; 35(12): 6869-75, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637909
9.
Prospective multi-center study for quantification of chemotherapies and CTX-related direct medication costs avoided by use of biomarkers uPA and PAI-1 in primary breast cancer.
Breast
; 22(4): 436-43, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23643802
10.
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer.
Breast Care (Basel)
; 7(4): 289-95, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23904831
11.
Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
J Clin Oncol
; 29(2): 242-8, 2011 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21115872